Ovid Therapeutics Inc (OVID) — Capital Reinvestment Ratio
Ovid Therapeutics Inc (OVID) has a Capital Reinvestment Ratio of 0.00x as of March 2021, meaning it reinvests 0% of its operating cash flow ($160.90 Million) in capital expenditures ($11.51K). See debt-free asset ratio of Ovid Therapeutics Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ovid Therapeutics Inc Capital Reinvestment Ratio (2021–2021)
This chart tracks Ovid Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check OVID total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Ovid Therapeutics Inc (2021–2021)
Year-by-year Capital Reinvestment Ratio for Ovid Therapeutics Inc from 2021 to 2021. For live market cap and broader valuation context, see Ovid Therapeutics Inc market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.00x | $118.61 Million | $184.01K | — |